A. From Treatment to Augmentation: The Gradual Shift of BCI

One night in January 2024, Noland Arbaugh couldn't sleep. Not because of pain. Because of a video game. Just weeks after surgery, he was playing Civilization VI all night long. He played chess. He raced in Mario Kart. For the first time since his diving accident at a lake eight years earlier, he could do what he wanted, by his own will. Without moving a single finger. With thought alone. The world was moved by what it saw. It was a victory for medical technology. A victory for the human spirit.

But in a conference room somewhere in Silicon Valley, a different conversation was taking place. Elon Musk saw Noland Arbaugh's case as a starting point. Not a destination.

The vision Musk held when he founded Neuralink in 2016 always reached beyond treatment. Symbiosis with artificial intelligence. Expanding the bandwidth of the human brain to keep pace with AI. He often pointed out that humans receive information far faster than they can output it.

We read thousands of words in an instant with our eyes, but to express those thoughts, we depend on slow finger-typing or even slower speech. In Musk's words, if humans don't break through this bottleneck, they risk being reduced to house cats in the age of AI.

This is where the line between treatment and augmentation begins to blur. The boundary looks clear on paper, but in practice it's a continuum. Consider this scenario. A technology is developed to implant electrodes in the hippocampus to restore memory in Alzheimer's patients. If this technology restores a patient's memory function to the level of their youth, it is clearly excellent medicine. But what if the same technology, with slight parameter adjustments, could let someone store the contents of a book after reading it once, like a photograph? What if a foreign language vocabulary list could be downloaded directly into the brain? At that moment, we leave the domain of treatment. We enter the domain of augmentation, artificially leapfrogging stages of evolution.

Neuralink's Blindsight project illustrates this ambiguity sharply. The technology stimulates the visual cortex to restore sight to blind individuals. In its early stages, it would show the world in low-resolution pixels, but as electrode density increases and algorithms grow more sophisticated, resolution will steadily climb. At some point, it will surpass natural human vision. Musk has already mentioned that this technology

could provide superhuman sight capable of seeing infrared or ultraviolet light. A chip implanted for treatment becomes, one day, a tool that grants abilities no ordinary person possesses.

This shift won't arrive suddenly. It creeps forward in increments we barely notice. We've already walked a similar path. Ritalin and modafinil, drugs for treating ADHD, quietly became "study pills" among students preparing for exams. Plastic surgery began with reconstructive work for burn victims, but cosmetic procedures now dominate the field. LASIK started as vision correction and became a lifestyle convenience.

BCI technology will follow the same trajectory. First, it will clear regulatory hurdles under the noble justification of helping patients. Once safety is proven, it will enter the consumer market under the rationale of improving quality of life. And finally, the fear of falling behind everyone else will become the force that makes the technology universal.

The pace of technological progress between 2024 and 2025 is making this prediction more realistic by the day. In December 2025, a research team from Columbia University and NewYork-Presbyterian Hospital announced a new BCI chip called BISC. Packing 65,536 electrodes and 1,024 channels onto a single chip, the device creates an ultra-high-speed wireless connection between brain and computer. The researchers said this technology would go beyond treating disabilities and open a future where humans and AI systems interact seamlessly. The transition from treatment to augmentation is already being formalized at the laboratory stage.

In May 2025, Apple released its BCI Human Interface Device Protocol. This protocol allows brain-computer interfaces to interact with Apple products. In August, Synchron demonstrated its BCI controlling an iPad. If you ask what the next interface after the smartphone will be, Silicon Valley's answer is growing clearer. It is the brain itself.

Within this gradual shift, we face a profound question. Where do human limits end? Weren't suffering, scarcity, and forgetting the very conditions that made us human? Can we still call a being that remembers everything, calculates at the speed of light, and communicates without speaking Homo sapiens? At the threshold between treatment and augmentation, humanity may need to redefine its own identity. A BCI is not just a medical device. It is the chisel humanity picked up to sculpt its own evolution.

B. Is Cognitive Augmentation a Privilege of the Wealthy?

Imagine an elementary school classroom in the 2040s. The teacher asks a question. Some children raise their hands before the question is even finished. Their brains are connected to the cloud. They don't need to memorize math formulas. The chip handles the calculations.

On the other side of the classroom, children are still rolling pencils between their fingers, struggling. The wall between the two groups doesn't come from a difference in effort. It is a biological gap born from a difference in their parents' wealth.

This may sound like a scene from a science fiction novel.

But data from 2024 suggests this scenario isn't far off. The cost of Neuralink's invasive BCI surgery is estimated at between 40,000 and 100,000 dollars, roughly 50 million to 130 million Korean won. In the early stages, the price will likely be much higher. On top of that come periodic software update fees, data usage charges, and maintenance costs. State-of-the-art brain implants will become a luxury only a small wealthy class can afford.

Until now, inequality has been environmental. Children from wealthy families attended better schools and received more expensive tutoring. But a child from a poor family, if blessed with genius and relentless effort, could narrow that gap to some degree. The biological hardware of the human brain was equal. The brain of a corporate tycoon and the brain of a poor laborer had no significant difference in basic processing speed or memory capacity.

BCI-driven augmentation shatters this biological equality. When the day comes that money can upgrade the brain's performance itself, inequality becomes permanent. The wealthy become smarter, learn faster, and think more creatively. They generate more wealth on the back of this superior cognition. They use that wealth to give their children even more powerful brain upgrades. This is a dystopia where social class leads to a biological speciation.

Historian Yuval Harari foresaw this in his book Homo Deus as the birth of god-like humans and a "useless class." Cognitively augmented super-humans could monopolize society's key decisions, while unaugmented natural humans, displaced by AI and automation, could lose their economic and political value entirely. The biological caste system he described could become reality.

In an academic paper published in October 2024, researchers at the University of Edinburgh analyzed this problem using the term "cognitive divide." They warned that unequal access to BCI could go beyond a digital divide and create a gap in human capability itself. At the same time, they raised a paradoxical concern. If everyone used the same BCI, cognitive homogenization could occur. If BCIs guide people to think in a particular way, the diversity of human thought could shrink.

The cost barrier doesn't stop at the purchase price. The device may operate on a subscription model. The latest firmware and model updates may require payment. Personalized learning requires accumulating data over long periods. If performance improves as data builds up, then people who can afford uninterrupted use have the advantage. In the end, the financial comfort to sustain continuous use determines performance.

Barriers to access also show up in infrastructure. You need a stable network, compatible devices, legal knowledge about personal data, the ability to review contracts and terms of service, and a safety net with alternatives if side effects arise. These are conditions that the socioeconomically privileged already have in place.

Labor market mechanics will amplify this inequality automatically. Companies favor tools that raise productivity. Once the perception spreads that BCI assistance improves focus, memory, and reaction speed in certain jobs, experience with the device becomes an unofficial credential. People who don't use one are disadvantaged not by lack of skill but by lack of equipment. The unspoken social norm could become: get a chip implanted if you want a job.

There is, of course, an optimistic view. The price of technology drops sharply over time. When smartphones first appeared, they were exclusive to the rich; now they are used in slums around the world. The cost of LASIK surgery has fallen far from what it was twenty years ago. The argument goes that once mass production is established, BCI will become a universal technology accessible to everyone.

But BCI is different from a smartphone. You can use an older smartphone model and still communicate just fine. But if your brain's processing speed is a hundred times slower than everyone else's, competing in society becomes impossible. If people fitted with the latest chip hold an overwhelming edge over those with an older model, we find ourselves trapped in an endless cycle of brain upgrades.

Ensuring that cognitive augmentation does not become a privilege of the wealthy will require strong social consensus and institutional safeguards. Should access to BCI be guaranteed within the public education system? Should health insurance cover cognitive augmentation procedures? Should the government provide "digital brain" subsidies to low-income populations?

These discussions aren't stories from science fiction novels. They will become real agenda items, fiercely debated in legislatures and courtrooms of the 2030s.

We must ask: in a society where intelligence becomes a commodity, how can human dignity be preserved? Can we accept a world where people are forced into cognitive decline because they can't afford otherwise? If technology is to serve as a tool that saves humanity, it must become a right for everyone, not a privilege for the few.

C. The Risk of Military and Surveillance Abuse

Technology is value-neutral, but the humans who wield it are not. Throughout history, the most groundbreaking technologies were tested on the battlefield first. The internet. GPS. The jet engine. Brain-computer interfaces sit at the very front of military interest today.

DARPA, the research agency under the U.S. Department of Defense, has been pouring enormous budgets into neurotechnology for decades. The N3 program, the Next-Generation Nonsurgical Neurotechnology program, carries a price tag of $104 million. Its goal is clear: develop high-performance, bidirectional brain-machine interfaces that healthy soldiers can use without surgery. DARPA program manager Al Emondi put it this way: 'Neural interfaces will be used wherever they are needed.'

From a military perspective, BCI could become the ultimate weapons system. It heralds the creation of super soldiers. Imagine a soldier who feels no fear, maintains razor-sharp focus after days without sleep, and downloads battlefield conditions directly into the brain for a 360-degree field of vision. Controlling a swarm of drones with thought alone. Telepathic communication, sharing operational plans with teammates without a single spoken word, would dramatically boost the effectiveness of special operations forces. Research along these lines is already underway. In 2019, DARPA awarded the BrainSTORMS project contract to a team led by Battelle Memorial Institute. The project develops injectable magnetoelectric nanoparticles. Small enough to fit thousands on a single strand of hair, these particles travel through the bloodstream to the brain, communicating with a helmet to read and write neural signals. When the mission ends, magnetic fields flush them out of the body.

A simulator experiment in which a quadriplegic pilot flew an F-35 fighter jet using brain signals alone has already succeeded. Preliminary experiments where a single person controlled a drone swarm through thought have also been conducted. A 2025 paper published in the International Review of the Red Cross projected that these technologies would dominate military systems by the early 2030s. The United States isn't alone. China, Russia, and France are all pursuing BCI research and development.

But the stronger the light, the darker the shadow. When this technology is abused as a tool of surveillance and control, the danger can be more covert and lethal than nuclear weapons.

The most alarming scenario is forced brain hacking. Consider an interrogation method that scans a captured enemy combatant's brain to extract classified information. Torture in the past inflicted physical pain to pry open mouths. BCI can bypass the will entirely and steal memories themselves. This is a new form of human rights violation that the Geneva Conventions never accounted for.

There is also the possibility of using these tools for domestic surveillance. In 2018, the South China Morning Post reported that some Chinese factories and high-speed rail operators were fitting workers and train drivers with brainwave-monitoring caps to track fatigue and emotional states. The State Grid Zhejiang Electric Power Company claimed this technology generated roughly $315 million in profit gains between 2014 and 2018. Companies cite productivity improvements as justification, but this marks the beginning of neural surveillance, where a worker's mental state is monitored and evaluated in real time.

An analysis published in the International Review of the Red Cross identifies the legal problems with military BCI. The researchers distinguished two modes. Active BCI is when a soldier consciously imagines pressing a button to issue a fire command. Reactive BCI is when, immediately after detecting a target, the soldier's brain signal is converted into a fire command before the soldier even consciously registers the target. The researchers concluded that reactive BCI violates Article 36 of the Additional Protocols to the Geneva Conventions because it escapes the soldier's

control. The principles of distinction and proportionality cannot be upheld.

There is also the danger of brainjacking, where a hacker seizes control of a brain implant. An enemy could hack a friendly soldier's brain chip to manipulate visual information or force the soldier to pull a trigger. They could stimulate pain centers to incapacitate someone. A situation where your own body moves not by your will but by a hacker's code. This is the most horrifying violation of physical autonomy imaginable.

Military competition is a tank with no brakes. Once one nation deploys brain-augmented soldiers, others will adopt even more powerful BCIs to keep pace. This triggers a neural arms race. Nuclear weapons at least maintain peace through deterrence, the logic of non-use. BCI can be deployed covertly and routinely, making it far harder to control.

We must not forget that this is a dual-use technology. The same technology that stops a Parkinson's patient's tremors can be repurposed to paralyze a healthy person. The same technology that improves memory can become a tool for erasing or manipulating memories. The international community must establish strict guidelines and treaties governing the military use of neurotechnology, just as it banned biochemical weapons. The brain must not become a battlefield. It is the last sanctuary where the human soul resides.

D. The Technology Gap and the Future of Neural Inequality

Picture a job posting from 2040. Required qualifications: compatible with Neuralink V5.0 or above; capable of processing one gigabit of data per second. This is not idle speculation. It is a glimpse of a future where the technology gap translates into physical and neural inequality.

We are already living through a digital divide. The economic and cultural gap between generations fluent in internet and smart devices and those who are not, between nations with strong IT infrastructure and those without, is already wide. But the neural divide that BCI could bring is on a different plane entirely. The digital divide was a gap in tools. The neural divide is a gap in being.

The gulf between augmented humans and those in a natural state could widen beyond the difference between Homo sapiens and Neanderthals. Augmented humans, fused with AI, solve complex problems in an instant. They connect in real time to global information networks. They regulate their emotions and biorhythms to optimal states. Meanwhile, natural humans struggle with hunger and fatigue. They make errors of memory. They communicate through slow language.

In the labor market, natural humans will lose their footing. Robots have already replaced simple physical labor. AI has replaced simple intellectual labor. Even highly creative and complex work will be monopolized by augmented humans armed with BCI. The term 'legacy human' may enter our vocabulary.

Market data from 2025 foreshadows this future. The invasive BCI market was estimated at roughly $160 billion in 2024. The total BCI market is projected to grow from about $2.87 billion in 2024 to over $15 billion by 2035. The compound annual growth rate exceeds 16%. Neuralink is valued at $5 billion. OpenAI invested $250 million in BCI startup Merge Labs. Capital is already betting on this future.

The most realistic near-term scenario is the spread of soft coercion. No law mandates it, but organizational culture and market norms make it compulsory in practice. Neural monitoring gets recommended as 'self-management' in high-performance roles. It gets tied to team-level productivity metrics. Individuals find it hard to refuse. Refusing makes you the person obstructing collaboration. This is the moment a medical technology morphs into labor discipline.

The second scenario is the emergence of the standardized human. As neurotechnology becomes widespread, society defines an 'average optimal state.' Standards are set for concentration levels, stress ranges, and sleep efficiency. People are nudged to conform. This leads to the shrinking of diversity. Creativity often emerges from unstable states. Deep thought sometimes arises from slow rhythms. But the market hates slowness. When neurotechnology redefines what counts as 'normal functioning,' those who fall outside the standard risk being classified as defective. The third scenario involves a division of roles between states and corporations. Governments introduce neurotechnology in the name of safety, public order, and national defense. Corporations introduce it for productivity, marketing, and risk management. When the two share data or use similar analytical models, individuals find it nearly impossible to escape either. Once a data infrastructure is built, repurposing it is easy.

The fourth scenario is the international gap. Nations with access to expensive implantable BCIs, high-performance closed models, and high-quality clinical data gain the upper hand in both treatment and augmentation. Technology-leading countries like the United States and China, backed by enormous capital and data reserves, seize control of BCI technology standards. They take the lead in boosting their citizens' cognitive capabilities. Meanwhile, nations with weak regulatory capacity or fragile data protection frameworks risk becoming testing grounds or cheap data suppliers. This gap amplifies beyond individual inequality into a competitive divide between nations. A new form of power imbalance, cognitive imperialism, could emerge.

The risks of applying a subscription economy model to BCI cannot be ignored either.

What happens when premium features or the latest knowledge updates for a brain implant require a monthly subscription fee? The moment someone can't pay due to financial hardship, they might suddenly lose a foreign language or see their work performance plummet. Just as Tesla controls vehicle functions through software updates, BCI companies could gain the power to remotely toggle a user's cognitive abilities on and off. A pop-up appearing before your eyes reading 'Your brain expires in 30 days' is not black comedy. It is a realistic fear.

In 2023, Second Sight, a company that made retinal implants for vision restoration, went bankrupt. Patients were left with unsupported devices still implanted in their eyes. It was a stark warning of how vulnerable bodies and data become when they depend on a technology company. Preventing neural inequality requires more than simple consent. It demands purpose limitation, prohibition of secondary use, data minimization, retention period limits, recognition of anonymization's boundaries, and severe penalties for violations.

To sum up, the future of neural inequality hinges not on the gap in device ownership, but on whether neural-data-based evaluation becomes the default setting of social institutions. The most dangerous future is a society where people believe they are freely designing themselves while actually being tuned to standardized optimization norms. In that society, inequality grows more insidious. It is no longer about being too poor to afford it. It becomes a structure where falling behind is the price of opting out. From that point on, individual choice is no longer a choice. It is a condition.

Before the technology gap hardens into neural inequality, we need to ask ourselves: what kind of future do we want? A world where meritocracy runs to its extreme and human worth is measured by the processing speed of a brain?

Or a world where technology fills in what the vulnerable lack, and everyone coexists while keeping their own dignity intact. That choice doesn't rest with technology. It rests with the ethical decisions we make right now.